0000899243-22-010181.txt : 20220309
0000899243-22-010181.hdr.sgml : 20220309
20220309163021
ACCESSION NUMBER:		0000899243-22-010181
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220307
FILED AS OF DATE:		20220309
DATE AS OF CHANGE:		20220309
REPORTING-OWNER:	
	OWNER DATA:	
		COMPANY CONFORMED NAME:			Montagut Etienne
		CENTRAL INDEX KEY:			0001861389
	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36569
		FILM NUMBER:		22725764
	MAIL ADDRESS:	
		STREET 1:		C/O LANTHEUS HOLDINGS, INC.
		STREET 2:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
ISSUER:		
	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
		CENTRAL INDEX KEY:			0001521036
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				352318913
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231
	BUSINESS ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
		BUSINESS PHONE:		978 671-8001
	MAIL ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
		DATE OF NAME CHANGE:	20110517
4
1
doc4.xml
FORM 4 SUBMISSION
    X0306
    4
    2022-03-07
    0
    
        0001521036
        Lantheus Holdings, Inc.
        LNTH
    
    
        
            0001861389
            Montagut Etienne
        
        
            C/O LANTHEUS HOLDINGS, INC.
            331 TREBLE COVE ROAD
            NORTH BILLERICA
            MA
            01862
            
        
        
            0
            1
            0
            0
            Chief Business Officer
        
    
    
        
            
                Common Stock
            
            
                2022-03-07
            
            
            
                4
                S
                0
                
            
            
                
            
            
                
                    3115
                
                
                    52.548
                
                
                    D
                
            
            
                
                    96634
                
            
            
                
                    D
                
            
        
    
    
        The Company requires certain senior executives to cover tax liabilities resulting from the vesting of their equity awards pursuant to sell-to-cover transactions in compliance with Rule 10b5-1. The transaction reported in this Form 4 was effected in compliance with Rule 10b5-1 to satisfy withholding tax liabilities of the Reporting Person associated with the vesting of restricted stock previously granted and reported on a previously filed Form 4.
    
    
    
        /s/   Daniel M. Niedzwiecki, attorney-in-fact
        2022-03-09